Home›Companies›Curve Biosciences

Curve Biosciences, Inc.

Updated Oct 27, 2026·Latest SEC filing May 13, 2024·Suggest an edit

About Curve Biosciences

Curve Biosciences is a private company based in Mountain View, California, incorporated in 2021 in Delaware. It has reported $17,691,996 raised in one offering on Form D since May 2024. Its chief executive is Ritish Patnaik.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 1, 2024May 13, 2024$17,691,996of $20.0M target64$276KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Curve Biosciences's Form D filed May 13, 2024.

CO
Chuba Oyolu
Executive officer
NH
Nathan Hunkapiller
Executive officer
SW
Shan Xiang Wang
Executive officer and director
TK
RP
Ritish Patnaik
Chief Executive Officer and director

Sources

  1. SECCurve Biosciences, Inc. filing history